Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Sadif Analytics (Premium)
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Akorn Inc receives FTC clearance for Hi-Tech Pharmacal Co Inc acquisition


Monday, 14 Apr 2014 07:00pm EDT 

Akorn Inc:Says that U.S. Federal Trade Commission (FTC) has voted to approve Akorn's acquisition of Hi-Tech Pharmacal Co Inc.Says unanimous vote in support of transactions follows Akorn's agreement to proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval.Parties have now obtained all regulatory approvals required to consummate the acquisition, and intend to close by end of this week. 

Related Company News

Company Quote

37.85
-0.12 -0.32%
19 Aug 2014